Doctors in Seattle who care for children with retinoblastoma, a rare, hereditary eye cancer, have…
karnottFebruary 3, 2025
Explore Now
News and Articles
The mammalian target of rapamycin (mTOR) pathway is a therapeutic target in polycystic kidney disease…
karnottFebruary 3, 2025
HDT Bio, a leader in advanced RNA vaccine technologies, is partnering with MalarVx to advance…
karnottJanuary 31, 2025
Washington Research Foundation (WRF) has awarded $93,030 over the next two years to support the…
karnottJanuary 31, 2025
Under the leadership of Sanjay Srivatsan, PhD, the Srivatsan Lab at the Fred Hutchinson Cancer Center…
sciencecityNovember 17, 2023
The Institute for Protein Design is proud to announce that our Executive Director, Lynda Stuart,…
sciencecityNovember 16, 2023
Dr. Abraham “Abe” B. Bergman, a pediatrician noted for leading many successful national efforts to…
sciencecityNovember 16, 2023
The ITHS Technology Development Center is excited to host a new training series aimed at…
sciencecityNovember 14, 2023
News and Articles
Ever since artificial intelligence (AI) drug developer Xaira Therapeutics launched in April 2024 with a…
karnottJune 25, 2025
CIS43LS is a long-acting monoclonal antibody specific for the Plasmodium falciparum circumsporozoite protein expressed on…
karnottJune 24, 2025
Washington Research Foundation (WRF) has awarded a $275,000 technology commercialization grant to Dr. David Koelle,…
karnottJune 24, 2025
Upcoming Events in Seattle
Stay up-to-date with all of the life science events taking place in Seattle with the Science in Seattle events calendar!
